Abstract：Objective To observe the occurrence of hyperamylaseemia after endoscopic retrograde cholangiopancreatography (ERCP), and to analyze the factors affecting the occurrence of hyperamylaseemia, aiming to provide the prevention and treatment of hyperamylaseemia after ERCP in the future guide. Methods The clinical data of 112 patients who underwent ERCP treatment at the Hospital of Shunyi District Beijing from October 2015 to June 2019 were retrospectively analyzed, and they were divided into groups based on whether postoperative hyperamylaseemia occurred or not, logistic multiple regression model was used to analyze the influencing factors of hyperamylaseemia after ERCP. Results All 112 patients developed hyperamylaseemia after ERCP in 24 cases, and 88 cases did not develop hyperamylaseemia after ERCP. The incidence rate was 21.43%. The proportions of common bile duct stenosis and duodenal papillary diverticulum in the occurrence group were higher than those in the non-occurring group, and the levels of PT, GGT and TG were higher than those in the non-occurring group, and the differences were statistically significant (P ＜ 0.05). Univariate and multivariate logistic regression showed that common bile duct stenosis, duodenal papillary diverticulum, high PT level, high GGT level, and high TG level were the influencing factors of hyperamylaseemia after ERCP (OR ＞ 1, P ＜ 0.05). Conclusion Common bile duct stenosis, duodenal papillary diverticulum, high PT level, high GGT level, and high TG level may increase the risk of hyperamylaseemia after ERCP. The clinic should pay attention to the implementation of reasonable interventions for patients with the above risk factors. It may be of positive significance to reduce the incidence and improve the prognosis.
周作玲 郭颖 杨娜. ERCP术后高淀粉酶血症发生情况及其影响因素分析[J]. 中国医药导报, 2021, 18(1): 103-106.
ZHOU Zuoling GUO Ying YANG Na. Analysis of the occurrence and influencing factors of hyperamylaseemia after ERCP. 中国医药导报, 2021, 18(1): 103-106.
2021, Vol. 18 
京公网安备 11010502046598号